Skip to main content
VRCA logo

VRCA · Verrica Pharmaceuticals Inc. · Short Interest

Track VRCA — free
$3.48 +0.01 (+0.29%) At close · Oct 28 Q2 2026 earnings call transcript
Market Cap
$59.27M
Shares
17.18M
Volume · Oct 28 22.18K Avg daily vol (3M) 68.7K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

VRCA Latest Reported Short Interest

FINRA reported 192,613 VRCA shares sold short as of the October 15, 2026 settlement date, a decrease of 3,608 shares. Days to cover was 3.84 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

VRCA Short Interest Forecast

Equibles' model estimates 174,517 shares sold short for the October 30, 2026 settlement, -9.4% versus the latest reported position, with a likely range of 140,370 to 205,669 shares. This model prediction uses FINRA data through October 28, 2026; FINRA's official release is expected November 10, 2026.

Model estimate

Expected Oct 30 short interest

as of Oct 28 High confidence 79% chance it falls
174,517 -9.4% vs reported
Likely range 140,370 to 205,669 The latest estimate appears in the chart below. Official release expected Nov 10. Methodology
Short Squeeze Score
37/100
Short interest 1.1% of shares — P41 Days to cover 3.8 — P55 Price vs VWAP -26.6% — P14 Short-volume trend -12.6% — P13 Short interest change -1.8% — P42 Worst FTD 0.01% of shares — P55

Positioning score 36.8 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-29 03:52 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 192,613 196,221 -3,608 3.84
2026-09-30 196,221 202,755 -6,534 4.06
2026-09-15 202,755 222,572 -19,817 4.18
2026-08-31 222,572 269,349 -46,777 1.42
2026-08-14 269,349 287,747 -18,398 5.16
2026-07-31 287,747 315,760 -28,013 9.84
2026-07-15 315,760 324,679 -8,919 11.07
2026-06-30 324,679 351,818 -27,139 6.30
2026-06-15 351,818 379,278 -27,460 9.26
2026-05-29 379,278 412,480 -33,202 9.35
2026-05-15 412,480 582,214 -169,734 3.56
2026-04-30 582,214 581,329 +885 7.38
2026-04-15 581,329 497,753 +83,576 6.81
2026-03-31 497,753 478,579 +19,174 3.94
2026-03-13 478,579 405,005 +73,574 3.16
2026-02-27 405,005 384,580 +20,425 3.89
2026-02-13 384,580 338,059 +46,521 2.38
2026-01-30 338,059 299,006 +39,053 2.49
2026-01-15 299,006 292,263 +6,743 1.89
2025-12-31 292,263 380,561 -88,298 1.37
2025-12-15 380,561 515,613 -135,052 1.38
2025-11-28 515,613 446,691 +68,922 1.00
2025-11-14 446,691 419,718 +26,973 6.84
2025-10-31 419,718 302,200 +117,518 1.13

Full FINRA short interest reporting calendar

Showing 1–24 of 24 settlements
Key facts CIK 1660334 CUSIP 92511W207 13F (30d) 2 filings 2 filers Visit website Investor relations